Detalles de la búsqueda
1.
Multicenter phase II study of capecitabine plus oxaliplatin in older patients with advanced gastric cancer: the Tokyo Cooperative Oncology Group (TCOG) GI-1601 study.
Gastric Cancer;
26(6): 1020-1029, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37610558
2.
[Re-Administration of Anti-EGFR Antibody Drugs for Unresectable Colorectal Cancer-Focusing on Tumor Markers].
Gan To Kagaku Ryoho;
50(8): 917-919, 2023 Aug.
Artículo
en Japonés
| MEDLINE | ID: mdl-37608421
3.
Multicenter, single-arm, phase II study of the continuous use of panitumumab in combination with FOLFIRI after FOLFOX for RAS wild-type metastatic colorectal cancer: Exploratory sequential examination of acquired mutations in circulating cell-free DNA.
Int J Cancer;
151(12): 2172-2181, 2022 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35723084
4.
A Case Report of Primary Unresectable Hilar Cholangiocarcinoma Causing Colonic Obstruction Due to Peritoneal Dissemination.
J UOEH;
44(3): 277-286, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36089346
5.
[Two Cases of Synchronous Double Primary Prostate Cancer Accompanying Bone Metastasis and Colon Cancer].
J UOEH;
43(1): 103-115, 2021.
Artículo
en Japonés
| MEDLINE | ID: mdl-33678780
6.
[A Case of Ascending Colon Cancer with Skull Metastasis].
J UOEH;
43(4): 433-443, 2021.
Artículo
en Japonés
| MEDLINE | ID: mdl-34897173
7.
Phase Ib/II Study of Biweekly TAS-102 in Combination with Bevacizumab for Patients with Metastatic Colorectal Cancer Refractory to Standard Therapies (BiTS Study).
Oncologist;
25(12): e1855-e1863, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32666647
8.
iPS cells: a game changer for future medicine.
EMBO J;
33(5): 409-17, 2014 Mar 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-24500035
9.
A Phase II Study of Third-Line Combination Chemotherapy with Bevacizumab Plus S-1 for Metastatic Colorectal Cancer with Mutated KRAS (SAVIOR Study).
Oncology;
91(1): 24-30, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27229742
10.
Perspectives for induced pluripotent stem cell technology: new insights into human physiology involved in somatic mosaicism.
Circ Res;
114(3): 505-10, 2014 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-24481841
11.
Multicenter randomized phase II clinical trial of oxaliplatin reintroduction as a third- or later-line therapy for metastatic colorectal cancer-biweekly versus standard triweekly XELOX (The ORION Study).
Int J Clin Oncol;
21(3): 566-72, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26475356
12.
Multicenter Phase II study of FOLFOX or biweekly XELOX and Erbitux (cetuximab) as first-line therapy in patients with wild-type KRAS/BRAF metastatic colorectal cancer: The FLEET study.
BMC Cancer;
15: 695, 2015 Oct 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-26467662
13.
[Current Status of Japanese Traditional Medicine 'Kampo' in Chemotherapy].
Gan To Kagaku Ryoho;
42(13): 2423-9, 2015 Dec.
Artículo
en Japonés
| MEDLINE | ID: mdl-26809300
14.
UGT1A1*6, 1A7*3, and 1A9*22 genotypes predict severe neutropenia in FOLFIRI-treated metastatic colorectal cancer in two prospective studies in Japan.
Cancer Sci;
104(12): 1662-9, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24033692
15.
Valpha14 NK T cell-triggered IFN-gamma production by Gr-1+CD11b+ cells mediates early graft loss of syngeneic transplanted islets.
J Exp Med;
202(7): 913-8, 2005 Oct 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-16186183
16.
Prospective phase II study of FOLFIRI for mCRC in Japan, including the analysis of UGT1A1 28/6 polymorphisms.
Jpn J Clin Oncol;
41(4): 477-82, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21303789
17.
[A case of pathological complete response after treatment with uracil/tegafur (UFT) and folinate (Leucovorin) for liver metastasis of colon cancer].
Gan To Kagaku Ryoho;
38(13): 2655-7, 2011 Dec.
Artículo
en Japonés
| MEDLINE | ID: mdl-22189237
18.
Invasive cribriform carcinoma of the breast detected incidentally on computed tomography: A case report.
Clin Case Rep;
9(12): e05214, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34950479
19.
Phase II study of an oxaliplatin-based regimen for relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy (INSPIRE study).
Cancer Chemother Pharmacol;
87(5): 665-672, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33555359
20.
The H-Invitational Database (H-InvDB), a comprehensive annotation resource for human genes and transcripts.
Nucleic Acids Res;
36(Database issue): D793-9, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18089548